Professional Documents
Culture Documents
CLASSIFICATION
DRUG NAME
Magnesium sulfate
MECHANISM OF ACTION
THERAPEUTIC USE
Seizure control.
CONTRAINDICATIONS
Avoid using for more than 5– 7 days for preterm labor (may increase risk of hypocalcemia
and bone changes in newborn).
Avoid continuous use during active labor or within 2 hr of delivery due to potential for
magnesium toxicity in newborn.
Availability: Injection: 500 mg/mL (50%). Premixed infusion: 1 g/100 mL, 2 g/100 mL, 4
g/50 mL, 4 g/100 mL, 20 g/ 500 mL, 40 g/1000 ml.
ADVERSE EFFECTS
CNS: drowsiness.
Resp: decrease respiratory rate.
CV: arrhythmias, bradycardia, hypotension.
GI: diarrhea.
MS: muscle weakness.
Derm: flushing, sweating.
Metabolism: hypothermia
INTERACTIONS
NURSING CONSIDERATIONS
RESURRECTION UNIVERSITY MEDICATION CARD
ASSESSMENT
PATIENT PROBLEM
Eclampsia/Pre-Eclampsia
IMPLEMENTATION
Initiate seizure precautions, B/P, ECG (magnesium sulfate); magnesium toxicity: thirst,
confusion, decrease in reflexes; I&O ratio; check for decrease in urinary output.
Patellar reflex (knee jerk) should be tested before each parenteral dose of magnesium
sulfate. If response is absent, no additional doses should be administered until positive
response is obtained
PATIENT/FAMILY EDUCATION
EVALUATION